First Republic Investment Management, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$144.95 - $152.29 $860,278 - $903,841	-5,935 Reduced 73.13%	2,181 $330,000
Q2 2022 Aug 16, 2022	SELL	$83.14 - $145.99 $928,590 - $1.63 Million	-11,169 Reduced 57.92%	8,116 $1.18 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $877,557 - $1.14 Million	-7,972 Reduced 29.25%	19,285 $2.29 Million
Q4 2021 Feb 09, 2022	BUY	$99.73 - $148.48 $635,878 - $946,708	6,376 Added 30.53%	27,257 $3.76 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $723,384 - $1.02 Million	7,318 Added 53.96%	20,881 $2.9 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $583,468 - $931,527	8,870 Added 189.0%	13,563 $1.32 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $300,680 - $430,582	4,693 New	4,693 $321,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account